Who owns Homology Medicines Inc?
- CUSIP Number: 438083107
Tip: Access positions for across all investors
Analyze quarterly positions in Homology Medicines with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Homology Medicines stock
Who bought or sold Homology Medicines Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
5AM Venture Management | 4.5M | $2.8M | 0% | Dec 2023 |
|
Vanguard Group | 1.9M | $1.2M | -5% | Dec 2023 |
|
Newtyn Management | 1.4M | $851k | 100% | Dec 2023 |
|
BML Capital Management | 748k | $455k | 100% | Dec 2023 |
|
Vivo Capital | 370k | $225k | 0% | Dec 2023 |
|
George Kaiser Family Foundation | 307k | $186k | 680% | Dec 2023 |
|
ADAR1 Capital Management | 294k | $179k | 100% | Dec 2023 |
|
Bank of America Corporation | 189k | $115k | -38% | Dec 2023 |
|
Tudor Investment Corporation | 116k | $70k | 0% | Dec 2023 |
|
Citadel Advisors | 73k | $44k | -92% | Dec 2023 |
|
Barclays | 54k | $33k | 0% | Dec 2023 |
|
Franklin Resources | 41k | $25k | 0% | Dec 2023 |
|
Assenagon Asset Management | 37k | $23k | 53% | Dec 2023 |
|
American Investment Services | 37k | $23k | 0% | Dec 2023 |
|
Virtu Financial | 34k | $21k | 100% | Dec 2023 |
|
Schechter Investment Advisors | 30k | $18k | 0% | Dec 2023 |
|
Goldman Sachs Group | 25k | $15k | -2% | Dec 2023 |
|
Jane Street | 24k | $14k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 22k | $13k | 0% | Dec 2023 |
|
Mariner Wealth Advisors | 20k | $12k | 0% | Dec 2023 |
|
Bank of New York Mellon | 19k | $12k | 0% | Dec 2023 |
|
Millennium Management | 17k | $11k | -85% | Dec 2023 |
|
Hsbc Holdings | 16k | $9.3k | 0% | Dec 2023 |
|
UBS Group | 14k | $8.3k | -6% | Dec 2023 |
|
Raymond James & Associates | 13k | $7.9k | -19% | Dec 2023 |
|
Dimension Capital Management Partners | 11k | $6.7k | 0% | Dec 2023 |
|
CI Private Wealth | 10k | $6.1k | 100% | Dec 2023 |
|
Wells Fargo & Company | 1.7k | $1.0k | 1% | Dec 2023 |
|
Rhumbline Advisers | 1.2k | $712.949400 | 0% | Dec 2023 |
|
Simplex Trading | 1.0k | $0 | 109% | Dec 2023 |
|
Jpmorgan Chase & Co | 954.00 | $580.032000 | 0% | Dec 2023 |
|
Advisory Services Network | 696.00 | $423.028800 | 100% | Dec 2023 |
|
Royal Bank of Canada | 332.00 | $0 | 100% | Dec 2023 |
|
Advisor Group Holdings | 280.00 | $169.988000 | 0% | Dec 2023 |
|
D. J. St. Germain | 200.00 | $122.000000 | 0% | Dec 2023 |
|
BFSG | 200.00 | $122.000000 | 100% | Dec 2023 |
|
Investors Research Corp | 160.00 | $96.992000 | 0% | Dec 2023 |
|
Coppell Advisory Solutions | 11.00 | $7.000400 | -54% | Dec 2023 |
|
Sachetta | 1.00 | $1.000000 | 100% | Dec 2023 |
|
Who sold out of Homology Medicines?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Western Standard | Sep 2023 | 250k | $293k |
Dimensional Fund Advisors | Sep 2023 | 118k | $138k |
DLK Investment Management | Dec 2023 | 60k | $37k |
Connor, Clark & Lunn Investment Management | Sep 2023 | 12k | $14k |
Two Sigma Securities | Sep 2023 | 10k | $12k |
Us Bancorp | Sep 2023 | 1.8k | $2.1k |
Ameliora Wealth Management | Dec 2023 | 1.5k | $912.000000 |
Bnp Paribas Arbitrage, Snc | Sep 2023 | 213.00 | $248.997000 |
Beaird Harris Wealth Management | Sep 2023 | 163.00 | $191.003400 |
Thompson Investment Management | Dec 2023 | 76.00 | $46.002800 |
Authentikos Wealth Advisory | Sep 2023 | 40.00 | $47.000000 |